日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Response to: Letter to the Editor Regarding "Comparative Effectiveness of FF/1 UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy"

回复：致编辑的信，内容关于“FF/1 UMEC/VI 和 BUD/GLY/FORM 在 COPD 患者从双联疗法升级治疗中的疗效比较”

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03477-0
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study

在慢性阻塞性肺疾病（COPD）患者中，根据急性加重情况和既往双联疗法分层，评估从双联疗法升级至FF/UMEC/VI和BUD/GLY/FORM方案的疗效：一项比较疗效研究的亚组分析

期刊:Advances in Therapy
影响因子:
doi:10.1007/s12325-025-03470-7
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data

利用美国商业和联邦医疗保险优势计划的理赔数据，评估慢性阻塞性肺病患者使用单吸入器三联疗法的依从性和持续性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03055-w
Young, Corinne; Lee, Lydia Y; DiRocco, Kristi K; Germain, Guillaume; Klimek, Jacob; Laliberté, François; Lejeune, Dominique; Noorduyn, Stephen G; Paczkowski, Rosirene
发表日期：2025
文献求助 收藏

Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)

美国医疗保险优势计划人群：接受 ICS/LABA 治疗的哮喘患者在开始使用糠酸氟替卡松/乌美溴铵/维兰特罗 (FF/UMEC/VI) 前后的治疗结果

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03083-6
Baptist, Alan P; Germain, Guillaume; Klimek, Jacob; Laliberté, François; Schell, Robert C; Forero-Schwanhaeuser, Sergio; Moore, Alison; Noorduyn, Stephen G; Paczkowski, Rosirene
哮喘
发表日期：2025
文献求助 收藏

Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease

在美国慢性阻塞性肺疾病患者中，氟替卡松糠酸酯/乌美溴铵/维兰特罗与布地奈德/格隆溴铵/富马酸福莫特罗的疗效比较

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03088-1
Mannino, David; Weng, Stephen; Germain, Guillaume; Boudreau, Julien; Tardif-Samson, Anabelle; Forero-Schwanhaeuser, Sergio; Laliberté, François; Gravelle, Patrick; Compton, Chris H; Noorduyn, Stephen G; Paczkowski, Rosirene
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy

FF/UMEC/VI 和 BUD/GLY/FORM 在 COPD 患者从双联疗法升级治疗中的疗效比较

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03295-4
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏

Real-World Evaluation of an EHR-Enabled Chronic Obstructive Pulmonary Disease Assessment Test

基于电子病历的慢性阻塞性肺疾病评估测试的真实世界评估

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S479853
Gaeckle, Nathaniel; Corazalla, Edward; Kelloway, Judy S; Liberman, Joshua N; Darer, Jonathan David; Kahle-Wrobleski, Kristin; Paczkowski, Rosirene; Parab, Purva; Ruetsch, Charles
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏

Retrospective Cohort Study of Elderly Users of Single- or Multiple-Inhaler Triple Therapy for the Treatment of Asthma in the USA

美国老年哮喘患者使用单吸入器或多吸入器三联疗法的回顾性队列研究

期刊:Pulmonary Therapy
影响因子:3
doi:10.1007/s41030-024-00285-9
Settipane, Russell A; Germain, Guillaume; Laliberté, Francois; Mahendran, Malena; Hilts, Annalise; Duh, Mei Sheng; Paczkowski, Rosirene; Burrows, Emmeline
哮喘
发表日期：2025
文献求助 收藏

A Brief Report on a Systematic Review of Real-World Effectiveness Studies of ICS/LAMA/LABA for Treatment of Adults with Asthma in the US

美国成人哮喘患者吸入性糖皮质激素/长效抗胆碱能药物/长效β2受体激动剂治疗真实世界疗效研究系统评价简报

期刊:Pulmonary Therapy
影响因子:3
doi:10.1007/s41030-025-00288-0
Noorduyn, Stephen G; Begaj, Kejsi; Martin, Amber; Forero-Schwanhaeuser, Sergio; Schaible, Kassandra; Moore, Alison; Paczkowski, Rosirene
信号转导
哮喘
免疫/内分泌
发表日期：2025
文献求助 收藏

Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study

哮喘患者从吸入性糖皮质激素/长效β2受体激动剂升级至氟替卡松/优维康/维罗替尼治疗后病情加重减少：回顾性队列研究

期刊:Pulmonary Therapy
影响因子:3
doi:10.1007/s41030-025-00327-w
Baptist, Alan P; Paczkowski, Rosirene; Germain, Guillaume; Klimek, Jacob; Laliberté, François; Schell, Robert C; Forero-Schwanhaeuser, Sergio; Moore, Alison; Noorduyn, Stephen G
信号转导
哮喘
免疫/内分泌
发表日期：2025
文献求助 收藏